Navigation Links
Specter Promises to Oppose Health Care Reform That Covers Illegal Aliens
Date:8/12/2009

WASHINGTON, Aug. 12 /PRNewswire-USNewswire/ -- During a town hall meeting Tuesday on health care reform, Senator Arlen Specter (D-Pa.) stated his opposition to legislation that would cover illegal aliens. Specter has been a long-time champion of amnesty for illegal aliens, he was the author of the 2006 amnesty bill (S. 2611) that was widely rejected by the American people. Specter's opposition to including illegal aliens under the proposed reforms is a clear indication of how strongly the public opposes the idea.

Facing constituents in Lebanon, Pennsylvania, yesterday, Specter said he "wouldn't support a bill that extends coverage to illegal immigrants." However, Specter went on to state erroneously that "none of the bills in Congress would provide health insurance to illegal immigrants."

A detailed analysis by the Federation for American Immigration Reform (FAIR) of the America's Affordable Health Care Act of 2009, H.R. 3200, reveals that illegal aliens would be eligible for government provided insurance, and could easily obtain government "affordability credits" to buy private insurance. An amendment that would have effectively prevented illegal aliens from receiving these benefits was blocked by Democrats on the House Ways & Means Committee. FAIR's analysis of the provisions of H.R. 3200 that pertain to illegal aliens can be found at www.fairus.org.

"FAIR commends Sen. Specter for opposing this costly benefit for illegal aliens," said Dan Stein, president of FAIR. "Illegal aliens and their dependent children account for as much as one-third of the medically uninsured in the U.S. Including them under the plan is unwarranted and would add billions to the price tag. We hope that the senator will use his influence in Congress to ensure that deliberate omissions and loopholes, like those in the House bill, that allow illegal aliens to benefit from taxpayer funded health care, will be corrected in the Senate."

The concerns raised by constituents at the Lebanon town hall meeting reflect the growing costs of illegal immigration both nationally and in Pennsylvania. According to a new report by FAIR, The Costs of Illegal Immigration to Pennsylvanians, state taxpayers spend nearly $49 million annually to provide health care to illegal aliens.

"In Pennsylvania and all across the nation, the public is understandably upset about the staggering costs of illegal immigration and adamantly oppose providing a full range of health benefits to illegal aliens," said Stein. "We hope that others in Congress join Sen. Specter in opposing any provisions that would require American taxpayers to provide the full spectrum of health benefits to illegal aliens."

About FAIR

Founded in 1979, FAIR is the country's largest immigration reform group. With over 250,000 members nationwide, FAIR fights for immigration policies that serve national interests, not special interests. FAIR believes that immigration reform must enhance national security, improve the economy, protect jobs, preserve our environment, and establish a rule of law that is recognized and enforced.


'/>"/>
SOURCE FAIR
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Pennsylvania Medical Society and AARP Criticize Senator Specter for Blocking Bill to Protect Access to Doctors and Improve Medicare
2. U.S. Senator Arlen Specter Addresses Constituents on Americas Healthcare Crisis
3. American Association for Cancer Research lauds Senator Arlen Specter
4. Senator Specter: Switching Parties or Coming Home?
5. Senators Arlen Specter and John Cornyn Will Discuss Medicare Issues at American Association for Homecare Legislative Conference, June 2-3, 2009
6. Best and Brightest Forum on Medical Innovation Brings Senator Arlen Specter, U.S. Representative Anna Eshoo, and Innovation Leaders Together in Washington, D.C., This Week
7. Senators Specter and Casey Vote to Protect Americas Kids from Tobacco
8. New way to diagnose Alzheimers disease promises earlier treatment
9. Cell growth technology promises more successful drug development
10. Hopes, Predictions and Realities: Is Biomedical Research Delivering On Its Promises?
11. UCF technique promises to aid doctors ability to identify, treat bacterial infections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology: